医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

CORRECTING and REPLACING Hytera Actively Participates in the Fight Against COVID-19, Helping to Prevent Cross-infections

2020年04月10日 PM08:26
このエントリーをはてなブックマークに追加


 

SHENZHEN, China

Please replace the release with the following corrected version due to multiple revisions of the release originally issued April 9, 2020, at 08:35 AM ET/April 9, 2020, at 05:35 AM PT.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200409005427/en/

A total of 1 million masks have already been donated by Hytera to the Philippines, Thailand, Myanmar, Russia, South Africa and other countries. (Photo: Business Wire)

A total of 1 million masks have already been donated by Hytera to the Philippines, Thailand, Myanmar, Russia, South Africa and other countries. (Photo: Business Wire)

The corrected release reads:

HYTERA ACTIVELY PARTICIPATES IN THE FIGHT AGAINST COVID-19, HELPING TO PREVENT CROSS-INFECTIONS

As of April 9, 2020, more than 1.5 million people have been diagnosed with COVID-19 worldwide, according to data from the World Health Organization (WHO). At this critical moment, Hytera, as a global leading provider of professional and private wireless communication networks, has taken immediate actions to provide diversified products in donations and service support to the countries and regions facing serious outbreaks of COVID-19. In addition, the company has also quickly tasked its smart production factory to switch over to mask production. A total of 1 million masks have already been donated by Hytera to the Philippines, Thailand, Myanmar, Russia, South Africa and other countries.

To support emergency response efforts against COVID-19, Hytera has donated DMR radios to Chevra Hatzalah to help protect their volunteers in New York City, the national epicenter of the COVID-19 pandemic. Chevra Hatzalah is the largest volunteer emergency medical service (EMS) organization in the world, with operations in 16 countries serving mostly Jewish communities.

One of the core values of professional and private wireless communications is to provide critical communications and command and dispatch support to governments and first response agencies to help ensure public safety during critical situations.

Globally, Hytera’s business solutions have been deployed throughout more than 120 countries and regions, and are used in private communications for public safety, transportation, emergency rescue and operator services to fight COVID-19. At present, many hospitals and police authorities in Spain, the United Kingdom, the Philippines, and Korea are fighting the outbreak with the support of Hytera’s communications solutions. In Abu Dhabi, a curfew was imposed as part of the prevention efforts during the epidemic. The police used Hytera’s multi-mode advanced radios to help control the movement of people in public areas.

Hytera is empowering people to manage and resolve the chaos created by the COVID-19 outbreak, and providing protection to prevent cross-infections among customs officers conducting border inspections, government officials discussing anti-epidemic programs and carrying out supervision, police monitoring checkpoints during the outbreak, rescue agencies deploying epidemic prevention materials and medical staff confronting the disease on the frontlines.

As a manufacturing company with world-class intelligent production capabilities, since February 10, Hytera has rapidly leveraged its advantages in intelligent production and supply chain integration to establish three production lines for mask production.

Beyond the efforts highlighted above, Hytera has also been developing its Pandemic Prevention Solution which focuses on supporting customs border inspections, hospital management and enterprise inspections, which will go to the market around April 10.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200409005427/en/

CONTACT

Shaowa Cai

Shaowa.cai@hytera.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease